Development of a novel virus-like particle vaccine-based cancer immunotherapy targeting PD-L1.
Ended Cooperative Agreement Awarded Last action
- Award ID
- R43CA217445
- Recipient
-
VLP Therapeutics, Inc. UEI M298V1FG5C14
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $292,964
Award facts
- Assistance listing
- 93.396 Cancer Biology Research
- Completion date
- Place of performance
- Gaithersburg, MD 20878, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$5,765 | |
| Original award | $298,729 |
Quick answers
Who received award R43CA217445?
R43CA217445 was awarded to VLP Therapeutics, Inc. by National Cancer Institute (National Institutes of Health) on September 20, 2017.
How much is award R43CA217445 worth?
$292,964 has been obligated on R43CA217445.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award